ArticleSurgical endoscopy2020
Endoscopic submucosal excavation and endoscopic full-thickness resection for gastric schwannoma: five-year experience from a large tertiary center in China.
Article in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 35 citations in OpenAlex.
- Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025).Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026Review
- Management of Gastrointestinal Schwannomas: A State-of-the-Art Review.Journal of gastrointestinal cancer · 2026Review
- Predictors for Achieving Textbook Outcomes After Endoscopic Resection of Giant Submucosal Tumors in the Esophagus and Cardia.Digestive diseases and sciences · 2026Article
- Endoscopic resection for gastric subepithelial tumours: a retrospective cohort study.Annals of medicine · 2025Article
- Ventral ETEP, results of our experience after exceeding 150 cases. Operative outcomes and learning curve.Hernia : the journal of hernias and abdominal wall surgery · 2025Article
- [Laparoscopic management of gastric schwannoma].Revista medica del Instituto Mexicano del Seguro Social · 2025Article
- Clinicopathological features and treatment of gastrointestinal schwannomas.World journal of gastroenterology · 2025Article
- A multicentre, prospective cohort study comparing two endoscopic procedures for the treatment of gastric muscularis propria lesions.Scientific reports · 2024Article
- Robotic-Assisted Minimally Invasive Resection of Multiple Oesophageal Schwannomas: A Case Report.Cureus · 2024Article
- Efficacy and Safety of Endoscopic Resection for Gastric Gastrointestinal Stromal Tumors Originating from the Muscularis Propria.Digestive diseases and sciences · 2024Article
- Same duodenal neuroendocrine tumors, different endoscopic resection methods: a case report and literature review.Frontiers in medicine · 2024Article
- Laparoscopic resection for gastric schwannoma larger than 30 mm with long-term outcomes.BMC surgery · 2023Article
- Schwannoma: A Rare Case of Submucosal Gastric Tumor.Diagnostics (Basel, Switzerland) · 2023Article
- Identification of gastric schwannoma and non-metastatic gastric stromal tumor by CT: a single-institution retrospective diagnostic test.Journal of gastrointestinal oncology · 2023Article
- The factors influencing the accuracy of pre-operative endoscopic ultrasonography assessment in endoscopic treatments for gastrointestinal tumors.Cancer medicine · 2023Article
- Endoscopic ultrasonography is useful for predicting perforation in the endoscopic resection of gastric submucosal tumors originating from the muscularis propria: a retrospective case-control study.Ultrasonography (Seoul, Korea) · 2023Article
- Natural history of gastrointestinal schwannomas.Endoscopy international open · 2022Article
- Laparoscopic-assisted endoscopic full-thickness resection of a large gastric schwannoma: A case report.World journal of gastrointestinal surgery · 2022Article
- Clinicopathological characteristics of gastrointestinal schwannomas: A retrospective analysis of 78 cases.Frontiers in oncology · 2022Article
- Safety and Efficacy of Endoscopic Treatment of Solitary Gastric Neurofibroma.International journal of general medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsEndoscopic resection (ER) is an effective and safe method for gastric submucosal tumors, mostly composed of gastrointestinal stromal tumors and leiomyomas. The role of ER in gastric schwannoma (GS) has rarely been described. Our aim was to evaluate the efficacy and safety of ER for GS.
methodsThis is a retrospective study in consecutive patients who underwent ER for GS from March 2013 to October 2018 at our center. Clinicopathological, endoscopic, and follow-up data were collected and analyzed.
resultsA total of 16 consecutive patients (9 females, 56.3%) were included, with a mean age of 50.4 years (range 25-75 years). The mean tumor size was 22.9 ± 15.1 mm (range 10-55 mm). Thirteen tumors (81.3%) were located in the middle third of the stomach and 12 tumors (75%) grew with intraluminal pattern. Endoscopic submucosal excavation (ESE) was performed in 7 patients while endoscopic full-thickness resection (EFTR) was done in 9 patients. R0 resection was achieved in 14 patients (87.5%). The mean operative time was 91.6 ± 52.8 min (range 36-203 min) and the mean postoperative length of hospital stays was 8.3 ± 2.7 days (range 6-13 days). No adverse events were encountered except for fevers in 2 patients. No patients required surgical resection or intervention. During long-term follow-up of mean 21.8 months (range 6-62 months), no residue, recurrence, or metastasis was observed.
conclusionsER is effective and safe for patients with GS with favorable long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.